Description
Provider of medical and clinical services. The company offers research and development services for therapeutics, it manages clinical work for VAL 201, a peptide for the treatment of refractory prostate cancer.
Contact Information
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|